The Claim
The overall omega-3 to omega-6 fatty acid ratio in plasma does not differ significantly between patients with mild and severe COVID-19, and the EPA/AA ratio is a more specific biomarker than the broader omega-3/omega-6 balance.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
The ratio of omega-3 to omega-6 fatty acids in the blood is similar in people with mild and severe COVID-19, but the ratio of EPA to AA is a more precise indicator of disease severity.
See the scientific wording
The overall omega-3 to omega-6 fatty acid ratio in plasma does not differ significantly between patients with mild and severe COVID-19, suggesting that the EPA/AA ratio is a more specific biomarker than the broader omega-3/omega-6 balance.
When there is more EPA than arachidonic acid in cell membranes, it reduces the production of inflammatory signals and prevents damage from harmful molecules formed during stress. This keeps the immune response from becoming too strong and causing severe illness.
What the research says
1 studyStudy: The severity of COVID-19 upon hospital admission is associated with plasma omega-3 fatty acids
The study found that the total amount of good fats (omega-3) vs. bad fats (omega-6) in the blood didn’t tell doctors if someone had mild or severe COVID-19. But the balance between two specific fats—EPA and arachidonic acid—did matter: people with more EPA and less arachidonic acid had less inflammation and got sicker less often.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.